NOBO Medicine
Biopharmaceutical and translational research organization focused on precision medicines and research into age-related immune dysfunction (clonal hematopoiesis). Integrates biomarker, genomic, imaging, and clinical cohort data to prioritize therapeutic candidates and guide clinical development for hematologic malignancies, chronic inflammatory diseases, and related cardiovascular and neurodegenerative conditions. Produces peer-reviewed translational and clinical publications and operates clinical-stage oncology programs alongside development of machine‑learning diagnostic tools.
Industries
N/A
Products
Clinical‑stage BTK/TEC pathway inhibitor programs
Clinical programs developing BTK/TEC pathway small‑molecule inhibitors for relapsed/refractory central nervous system and systemic B‑cell lymphomas, evaluated in combination regimens.
Preclinical small‑molecule hemato‑inflammation programs
Early discovery programs targeting inflammatory and myeloproliferative mechanisms including caspase and JAK2 pathway inhibitors.
Machine‑learning clinical decision support tool for TMA
An ensemble ML model and web‑based nomogram validated for differential diagnosis of thrombotic microangiopathy using multicenter clinical datasets.
Clinical‑stage BTK/TEC pathway inhibitor programs
Clinical programs developing BTK/TEC pathway small‑molecule inhibitors for relapsed/refractory central nervous system and systemic B‑cell lymphomas, evaluated in combination regimens.
Preclinical small‑molecule hemato‑inflammation programs
Early discovery programs targeting inflammatory and myeloproliferative mechanisms including caspase and JAK2 pathway inhibitors.
Machine‑learning clinical decision support tool for TMA
An ensemble ML model and web‑based nomogram validated for differential diagnosis of thrombotic microangiopathy using multicenter clinical datasets.
Services
Clinical development and trial management
Design and conduct of multicenter clinical studies including IND preparation and Phase I/II execution.
Biomarker and genomic data analysis
Genomic sequencing analysis, biomarker selection, and translational study analytics to inform development decisions and publications.
Regulatory strategy and licensing support
Support for regulatory filings, orphan designation processes, and partnership negotiations for technology transfer.
Translational cohort analytics and publication support
Design and analysis services for observational cohorts, sequencing studies, imaging biomarker integration, and manuscript preparation for peer‑reviewed journals.
Clinical development and trial management
Design and conduct of multicenter clinical studies including IND preparation and Phase I/II execution.
Biomarker and genomic data analysis
Genomic sequencing analysis, biomarker selection, and translational study analytics to inform development decisions and publications.
Regulatory strategy and licensing support
Support for regulatory filings, orphan designation processes, and partnership negotiations for technology transfer.
Translational cohort analytics and publication support
Design and analysis services for observational cohorts, sequencing studies, imaging biomarker integration, and manuscript preparation for peer‑reviewed journals.
Expertise Areas
- Precision medicine and translational platform development
- Clonal hematopoiesis and hematologic‑cardio‑neuro translational research
- Oncology drug development and early‑phase clinical trials
- Biomarker discovery, validation, and imaging biomarker integration
Key Technologies
- Targeted deep sequencing (high‑depth panels)
- Linked‑read sequencing for haplotyping
- Next‑generation sequencing (NGS) analysis pipelines
- Ensemble machine learning and predictive classifiers